Investing Profile
Michael Aberman
Your Intro Paths to Michael Aberman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
The Wharton School Network
841 CONNECTIONS
Morgan Stanley Network
707 CONNECTIONS
Cornell University Network
391 CONNECTIONS
Credit Suisse Network
322 CONNECTIONS
My Perfect Sale (acquired by Sugar, Inc) Network
176 CONNECTIONS
Find Michael Aberman on
cbCurrent Investing Position
Regeneron Ventures General Partner
Investment Range
$100K - $2.0M
Sweet Spot
$1M
Investments On Record
1
Michael Aberman is on these Sector & Stage Rankings
Michael Aberman's Investments On Record (1)
Sign in to see all 1 investments on record.
Sign in with Google →Michael Aberman's Experience
General Partner Regeneron VenturesPresent
General Partner My Perfect Sale (acquired by Sugar, Inc)Present
President and CEO Quentis Therapeutics, IncPresent
President and CEO My Perfect Sale (acquired by Sugar, Inc)Present
Board Member XenImmune Therapeutics, Inc.Present
Board Member My Perfect Sale (acquired by Sugar, Inc)Present
Business Advisor Excision BioTherapeuticsPresent
Board Member Unnatural ProductsPresent
Board Member Unnatural Products Inc.Present
SeniorAdvisor ImmunaiPresent
Board Member Rover DiagnosticsPresent
Senior Vice President, Strategy and Investor Relations RegeneronPresent
Biotech Analyst Credit SuissePresent
Biotech Analyst Morgan StanleyPresent
Senior Director, Business Development AntigenicsPresent
Resident NewYork-Presbyterian HospitalPresent
General Partner Quentis Therapeutics, IncPresent
Board Member Quentis Therapeutics, IncPresent
General Partner CnationPresent
President and CEO CnationPresent
Board Member CnationPresent
Michael Aberman's Education
Cornell University BA Biology
University of Toronto MD Medicine
The Wharton School MBA Healthcare
Investors who invest with Michael Aberman
Sign in with Google →Scouts & Angels Affiliated With Michael Aberman
Sign in with Google →